Macrophages are heterogeneous multifunctional leukocytes which are regulated in a tissue-and disease-31 specific context. Many different studies have been published using in vitro macrophage models to study 32 disease. Here, we aggregated public expression data to define consensus expression profiles for eight 33 commonly-used in vitro macrophage models. Altogether, we observed well-known but also novel markers 34 for different macrophage subtypes. Using these data we subsequently built the classifier macIDR, capable 35 of distinguishing macrophage subsets with high accuracy (>0.95). This classifier was subsequently applied 36 to transcriptional profiles of tissue-isolated and disease-associated macrophages to specifically define 37 macrophage characteristics in vivo. Classification of these in vivo macrophages showed that alveolar 38 macrophages displayed high resemblance to interleukin-10 activated macrophages, whereas 39 macrophages from patients with chronic obstructive pulmonary disease patients displayed a drop in 40 interferon-γ signature. Adipose tissue-derived macrophages were classified as unstimulated macrophages, 41 but resembled LPS-activated macrophages more in diabetic-obese patients. Finally, rheumatoid arthritic 42 synovial macrophages showed characteristics of both interleukin-10 or interferon-γ signatures. Altogether, 43 our results suggest that macIDR is capable of identifying macrophage-specific changes as a result of 44 tissue-and disease-specific stimuli and thereby can be used to better define and model populations of 45 macrophages that contribute to disease. 46 47 Page 3 of 23 MAIN TEXT 48 49 transcriptomic alteration associated with inflammation, infection, wound healing, and tumor growth. 64 However, compared to in vitro MDM activation, in vivo macrophage activation represents a complex and 65 dynamic process driven by multiple local factors. The most comprehensive study to date on gene 66 expression profiling of in vitro macrophages was performed by Xue et al., where the authors activated 67 MDMs under various conditions and identified distinct stimulus-specific transcriptional modules (5). Their 68 results suggested a broader view of how macrophages react upon divergent stimulation, thereby extending 69 the classical dichotomous pro-and anti-inflammatory model to an activation spectrum. While there have 70 been attempts to summarize published studies in an effort to attain consensus (4), a proper integrative 71 analysis has thus far not been performed. Furthermore, it remains unclear to what extent the in vitro 72 macrophage-models resemble their in vivo counterparts and which specific subtypes associate with 73 disease. 74
Introduction 50
Macrophages are multifunctional innate immune cells that play a central role in the spatiotemporal 51 regulation of tissue homeostasis between pro-inflammatory defense and anti-inflammatory tissue repair. 52
Dysregulation of macrophages has been implicated in a variety of disorders. As in vivo macrophages are 53 often difficult to obtain and study, in vitro peripheral blood monocyte derived macrophages (MDMs) have 54 been used extensively as model systems for assessing the transcriptional and functional regulation in 55 response to various stimuli. 56
To mimic in vivo macrophages encountering different microenvironmental signals (1, 2), MDMs, 57 differentiated with for example macrophage-(M-CSF), or granulocyte-macrophage stimulating factor (GM-58 CSF), are activated in vitro with bacterial lipopolysaccharides (LPS) or Th1 cytokine interferon gamma 59 (IFNγ) to generate pro-inflammatory macrophages (M1). Anti-inflammatory macrophages (M2) are often 60 generated by activating the cells with Th2 cytokines, interleukin-4 (IL4), or other anti-inflammatory stimuli, 61 such as interleukin-10 (IL10), tumor growth factor (TGF) and glucocorticoids (1-6). By applying these pro-62 or anti-inflammatory stimuli to the MDMs, researchers sought to obtain proper models for studying the 63 R package called macIDR (https://github.com/ND91/macIDR). 136
To validate our model, we tested macIDR against the previously withheld test set, which included 137 a newly-generated RNA-seq experiment containing all included activation states. Classification of the test 138 set revealed an accuracy above 0.95 with both high sensitivity (>0.98) and specificity (> 0.83; Table 2 ). In 139 total, 75 out of 79 test samples were correctly classified (Fig. 2B) . Notably, for three of the four 140 misclassified samples, the second-best prediction was the subset as reported by the authors. Investigation 141 of the four misclassified samples revealed that most errors were made regarding M0: two M0 datasets 142 were classified as M-IL10 (GSM151655) and M-IFNγ (GSM1338795), and one M-dex dataset (d54D) as 143 M0. The fourth misclassification pertained a M-LPS late (GSM464241) dataset classified as M-LPS+IFNγ 144 ( Fig. 2C) . 145 Pathway analysis of the predictor genes revealed a clear enrichment for inflammatory pathways, 146 such as TNFα signaling, inflammatory response and interferon gamma signaling, confirming the 147 importance of inflammation regulation in macrophage activation ( Fig. 2D , Table S3 ). A follow-up 148 transcription factor motif analysis on the promoters of the predictor genes showed significant enrichment 149 for macrophage transcription factors, the E26 transformation-specific PU.1 (Spi1) and SpiB ( Fig. 2E) . 150
MacIDR generalizes to granulocyte-macrophage colony-stimulating-factor differentiated 151 macrophages 152 Besides M-CSF, granulocyte-macrophage colony-stimulating-factor (GM-CSF) is often used to differentiate 153 monocytes to macrophages, where it is thought to evoke a more pro-inflammatory phenotype (36) (37) (38) . We 154 investigated whether macIDR was capable of discerning GM-CSF-differentiated MDMs (GM-MDMs) 155 exposed to various stimuli. In total, we obtained 31 datasets from three microarray studies (5, 16, 39) 156 where GM-MDMs were activated with LPS (GM-LPS early , GM-LPS late ), IFNγ (GM-IFNγ), and IL4 (GM-IL4), 157 or remained unstimulated (GM0). These studies were selected based on their similarity in activation 158 duration with the M-CSF differentiated macrophages used in the training set. We observed that all MDMs were classified as their M-CSF counterparts (Fig. 3B ) despite the fact that some predictive genes 160 were absent from two studies (Table S4 ). Our results indicate that the predictor genes for M-LPS early , M-161 LPS late , M-IFNγ and M-IL4 are representative for the activation regardless of whether M-CSF or GM-CSF 162 was used for differentiation. 163
Non-macrophage cells classify as M0 whereas monocyte-derived dendritic cells classify as M-IL4
164
To understand the limitations of macIDR, we investigated its performance on non-MDM cells. Datasets 165 were obtained of monocyte-derived dendritic cells (MoDC) (5, 39), various T lymphocyte subtypes (T), B 166 lymphocytes (B), neutrophils (NP), and natural killer cells (NK) (16, 40) , as well as fibroblast-like 167 synoviocytes (FLS) (27) . 168
The MoDCs were primarily recognized as M-IL4 regardless of subsequent LPS maturation or other 169 pro-inflammatory stimulation (Fig. 3C ). Spurious classification was ruled out as GM0 and GM-LPS late 170 datasets from the same studies were correctly classified as described previously. Investigation of the M-171 IL4 predictor genes revealed that concordant expression of monoamine oxidase A (MAOA) and lower 172 discordant expression of C-X-C motif chemokine 5 (CXCL5) of MoDCs were likely the main contributing 173 factors towards the M-IL4 classification (Table S4) . By contrast, we found that the FLS, T, B, NP and NK 174 cells were all classified as M0 ( Fig. 3A ), suggesting that the M0 class is used as a label for expression 175 profiles of non-monocyte-derived cells. By looking at the distribution of the log odds we observed that true 176 M0 classifications generally displayed higher log odds than the M0 classifications of most non-macrophage 177 cells, but found this not to be definite (Fig. 3D ). The increased variance for the M0 signal observed for GM-178
MDMs and MoDCs was due to the different GM-MDMs activation and DC maturation states, as GM0 and 179 up to some extent DC0, depicted M0 log odds similar to true M0 samples. 180
Alveolar macrophages from COPD and smoking individuals show a reduced M-IFNγ signal 181
We next attempted to classify macrophages derived from patient tissues to study their semblance to in 182 vitro generated MDMs. We investigated alveolar macrophages (AMs) obtained through bronchioalveolar 183 lavage from smoking individuals, COPD patients, asthma patients (31), and healthy control (HCs). Overall, 184
we found that the AMs were classified primarily as M-IL10 ( Fig. 4A and Table S10 ), which appears to be 185 driven by the MARCO signal. This corroborates the observation that lung tissue, specifically AMs, display 186 significantly higher gene expression of MARCO relative to surrounding cells and other tissues (41, 42) . 187
Moreover, MARCO was found to be necessary in AMs for mounting a proper defense response (41-43). 188
Further comparisons of the AMs derived from different patient groups, we found that the macrophage 189 signal could be stratified according to health status where COPD-and smoker-derived AMs displayed a 190 higher M-IL4, M-IL10 and M-dex signal and a reduced M-IFNγ and M-LPS+IFNγ signal compared to AMs 191 obtained from HCs. This observation indicates a stronger M2-and lesser M1-like phenotype, which was 192 also noted in previous studies (5, 31) . This difference in classification signal was found to be driven by a 193 decreased log odds for CXCL9 (M-IFNγ and M-LPS+IFNγ) and CXCL5 (M-IL4) and increased log odds for 194 TNFAIP6 (M-IL10), and ADORA3 (M-dex; Fig. S2 ).
Page 7 of 23 Furthermore, while no clear differences were observed when comparing AMs from asthma 196 patients to HCs, AMs from steroid-sensitive asthma patients displayed a decreased M-dex signal and 197 increased M-LPS early , M-IFNγ and M-LPS+IFNγ signal relative to steroid resistant asthma AMs (Fig. 4A) . 198
The apparent difference in steroid sensitivity appeared to be caused by a difference in TNF and CXCL9 199 signals contributing to the M-IFNγ and M-LPS+IFNγ classification respectively ( Fig. S2 ). This observation 200 corroborates previous studies where IFNγ signaling was found to suppress glucocorticoid-triggered 201 transcriptional remodeling in macrophages leading to the macrophage-dependent steroid-resistance, 202 thereby reflecting a higher level of IFNγ in steroid-resistant relative to steroid-sensitive asthma patients. 203
Adipose macrophages show a M0 and M-IL4 classification

204
We next investigated visceral adipose tissue macrophages (ATM) derived from diabetic and non-diabetic 205 obese patients (34). Classification analysis suggested visceral ATMs showed most similarity with M0 206 followed by M-IL4 ( Fig. 4B ). While we were not capable of defining a set of genes responsible for the M0 207 classification, we observed that the concordant expression of MAOA and C-C chemokine ligand 18 208 (CCL18) contributed the most to the M-IL4 signal ( Fig. S3 ). MAOA encodes a norepinephrine degradation 209 enzyme and is expressed more in sympathetic neuron-associated macrophages isolated from the 210 subcutaneous adipose tissue. In these cells, MAOA's norepinephrine clearance activity has been linked to 211 obesity (44). Interestingly, when comparing ATMs from diabetic obese with non-diabetic obese patients, 212
we observed a stronger signal of M-IL10 and M-LPS early driven by CCL18 and TNF respectively ( Fig. S3 ). 213
Notably, CCL18 expression in both visceral and subcutaneous adipose tissue has been associated with 214 insulin-resistant obesity (45, 46) . Furthermore, several studies have demonstrated that ATMs could be 215 IFNγ predictor gene C-X-C Motif Chemokine Ligand 9 (CXCL9) and for M-IL10 predictor gene Macrophage 230
Receptor With Collagenous Structure (MARCO; Fig. S4 ). This observation agrees with previous studies 231
where elevated gene and protein expression of CXCL9 was found in the synovium of RA patients 232 
Discussion
237
In this study, we performed a macrophage characterization study by integrating public datasets of eight in 238 vitro macrophage activation states. Our meta-analysis returned both well-known and novel markers for 239 activated macrophages. At a genome-wide level, we observed separation according to the conventional 240 pro-and anti-inflammatory macrophages. We subsequently built a classification model capable of 241 discriminating macrophage activation states based on their transcriptomic profile and made this available 242 as an R package called macIDR. By applying macIDR to in vivo macrophages, we projected the latter onto 243 the eight in vitro macrophage models providing insights in how disease and tissue of origin affected the 244 predicted composition. 245
Previous macrophage characterization studies focused primarily on gathering large cohorts. Xue et 246 al. adopted an inclusive strategy by categorizing genes into different activation states through self-247 organizing maps and correlation analyses (5). Instead, we sought to find consensus from published data 248 by implementing a descriptive and an exclusive strategy representing the meta-analysis and the elastic net 249 classification analysis respectively. Where the meta-analysis identified genes that were consistently 250 differentially expressed across studies when comparing stimulated with unstimulated MDMs, elastic net 251 classification analysis represented a rigorous feature selection approach that yielded predictor genes 252 capable of classifying the eight in vitro MDMs with high accuracy. We implemented an additional layer of 253 robustness by performing repeated cross-validation to ensure that the final output of the elastic net 254 regression was stable. Similarly, immature MoDCs (DC0) displayed a slightly higher response for M0. All other non-macrophage 267 cells were classified as M0. While the log odds of proper M0 classifications were slightly higher than 268 improper M0 classifications, we acknowledge that no clear threshold could be defined. We are unsure why 269 M0 was predicted as a class for non-MDM and non-MoDC datasets, but we speculate that it might be 270 related to the M0 class being represented by most predictor genes relative to the other classes. We 271 therefore recommend potential users of macIDR to determine a priori that their dataset of interest 272
Page 9 of 23 represents macrophages either experimentally or using in silico cell-composition estimation methods, such 273 as CIBERSORT (54) or xCell (55). 274
As macIDR was capable of properly classifying differentially differentiated in vitro MDMs, we 275 applied it to in vivo macrophages with the goal of extracting subpopulation information. When comparing 276 tissue-derived macrophages among different patient groups and healthy donors, we observed differences 277 in predictions, such as reduced signals of M-IFNγ and M-LPS+IFNγ and increased signals of M-IL4, M-278 IL10 and M-dex when comparing AMs from COPD patients with HCs. Moreover, we observed that the 279 tissue of origin had a large impact on the macrophage classification with in vivo macrophages obtained 280 from HCs not always being classified as M0 as was observed for the AMs. Since some in vivo 281 macrophages obtained from healthy tissue were classified as in vitro activated MDMs, unstimulated in vitro 282
MDMs likely do not reflect the basal state of all tissue-resident macrophages underpinning the importance 283 of how multiple factors in the microenvironment shape the transcriptome. Our results suggest that for 284 some in vitro models, using activated MDMs might achieve a more comparable phenotype to the in vivo 285 tissue macrophages that express the tissue transcriptomic signatures. 286
Unlike the AMs, no transcriptomic data was available of SMs from healthy donors. We were 287 therefore unable to conclude whether the M-IL10 and M-IFNγ predictions observed for the samples from 288 RA patients were tissue-specific or disease-associated. Though samples from different studies were 289 classified as M-IL10 or M-IFNγ, these two activation states appeared to be the highest two predicted 290 classes for SMs from RA patients among all recruited datasets. Notably, M-IL10 and M-IFNγ represent 291 predictions on opposite sides of the conventional inflammatory spectrum. Characterization studies on RA-292 SMs suggested that they represent multiple subpopulations, such as the CD163 + anti-inflammatory tissue-293 resident macrophages and the S100A8/9 + pro-inflammatory macrophages recruited from peripheral 294 monocytes (56). 295
As in vivo macrophages likely represent a more heterogeneous population compared to the in vitro 296
MDMs used in building the classifier, prediction of macrophage mixtures using bulk RNA-seq or microarray 297 returns signals from multiple different subsets. The classification therefore mainly reflects altered subset 298 proportions due to disease progression or association. It is likely that some in vivo macrophage 299 subpopulations do not share transcriptomic signatures with any of the eight in vitro MDMs preventing the 300 exact characterization thereof. Future studies using single cell RNA-sequencing should aim at defining 301 novel additional in vivo macrophage subsets. Nonetheless, we were capable of extracting signals from the 302 in vivo macrophage classifications that not only corroborated previous findings, but also provided novel 303 features for future research. It is essential to analyze macrophage subsets within the context of their in 304 vivo environment and therefore we provide this quantitative method to aid researchers in better defining 305 and modelling macrophages in tissue and disease. The initial screen was limited to studies that investigated primary macrophages and excluded the 315 stem cell derived macrophages or immortalized cell lines. Then we categorized macrophage subsets 316 based on the stimuli and the treatment time. For each subset, we sought to obtain at least 4 studies 317 including at least 2 biological replicates. Further, as a background control, only studies including 318 unstimulated control macrophages were selected. After this screening, we investigated macrophages 319 stimulated with control medium, LPS (either for 2 to 4 hours or 18 to 24 hours), LPS with IFNγ, IFNγ, IL4, 320 IL10 or dexamethasone for 18 to 24 hours. Microarray datasets generated on platforms other than 321
Illumina, Affymetrix or Agilent were excluded to ensure comparability. As we only investigated genes that 322
were measured in every single study, datasets that displayed limited overlap in the measured genes with 323 the other studies were removed. The in vivo macrophage datasets were samples obtained from clinical 324 specimen. In total, we obtained 206 datasets belonging to 19 studies for the meta-analysis and 325 classification. 326
Meta-analysis
327
A random effects meta-analysis was performed on the normalized data using the GeneMeta (v1.52.0) (57) 328 package, which implements the statistical framework outlined by Choi et al. (25) . In short, the standardized 329 effect size (Cohen d adjusted using Hedges and Olkin's bias factor) and the associated variance were 330 calculated for each study by comparing each activated macrophage with the unstimulated macrophage 331 within each study. The standardized effect sizes were then compared across studies by means of random 332 effects model to correct for the inter-study variation, thereby yielding a weighted least squares estimator of 333 the effect size and its associated variance. The estimator of the effect size was then used to calculate the 334 Z-statistic and the p-value, which was corrected for multiple testing using the Benjamini-Hochberg 335 procedure. We modified the GeneMeta functions to incorporate the shrunken sample variances obtained 336 from limma (58) for calculating the standardized effect sizes. 337
Classification
338
Raw microarray and RNA-seq data were log 2 transformed where necessary after which the data was 339 (inner) merged and randomly divided into a training (2/3) and test set (1/3). As the test set should remain 340 hidden from the training set, raw microarray and RNA-seq data was used instead of normalized data to 341 prevent data leakage (59). Elastic net regression was subsequently performed using the R glmnet (v2.0) 342 (60) package. As penalized regression approaches are sensitive to the magnitude of each feature, we 343 investigated the use of standardization. As the lowest deviance appeared to be higher in the inter-fold 344 standardized training set relative to raw data, we did not include any standardization (Fig. S1 ). We also 345 investigated the optimal alpha for minimizing the deviance by means of an initial grid search approach, 346 which was found to be 0.8. 347
The training set was subjected to ten-fold cross-validation for tuning the penalty regularization 348 penalty parameter lambda. This process was subsequently repeated 500 times to stabilize the 349 Page 11 of 23 randomness introduced during the splitting step for cross-validation (35). We considered genes to be 350 stable classifiers if they displayed a non-zero log odds ratio in at least 50% of the 500 iterations. The final 351 log odds ratio was selected by taking the median of each stable predictor gene across the 500 iterations. 352
We subsequently validated our classifier on the withheld test set. 353
In addition to the training and test data, we downloaded and imported additional datasets from 354 GM-MDMs, non-macrophage cells, and in vivo macrophages. Subsequent classification was performed 355 using the macIDR package. Unlike the studies included for training and testing, some of the included 356 studies were performed on platforms that did not measure the expression of some of the predictor genes. 357
To that end, the relative log odds ratios were calculated, which represent the log odds ratio present relative 358 to the total log odds ratio had all predictor genes been present. 359
Human monocyte-derived macrophage differentiation and stimulation 360 Buffy coats from three healthy anonymous donors were acquired from the Sanquin blood bank in 361
Amsterdam, the Netherlands. Monocytes were isolated through density centrifugation using Lymphoprep™ 362 (Axis-Shield) followed by human CD14 magnetic beads purifcation with the MACS® cell separation 363 columns (Miltenyi). The resulting monocytes were seeded on 24-well tissue culture plates at a density of 364 0.8 million cells/well. Cells were subsequently differentiated to macrophages for 6 days in the presence of 365 Acknowledgments 521 522
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